Delivery Order SPE2DB20D7059-SPE2DB25FQHT4
- Not listed
- The Defense Logistics Agency awarded a $1,270.82 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Nalbuphine 100 mg/10 ml vials. This is a firm fixed price, non-set-aside delivery order with a completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,228.36 firm-fixed-price delivery order is for the supply of 4,565,119,617 units of the prescription medication Nalbuphine 100 mg/10 ml vial. The contract has a completion date of July 12, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,500.77 firm fixed-price order is for the supply of 100 mg/10 ml vials of the drug Nalbuphine. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. This order is part of AmerisourceBergen's $999,999,999 IDC with DLA Troop Support Medical,...
- This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 10 mL vials of the injectable pain medication Nalbuphine. The contract, valued at $1,241.29, is a firm fixed-price delivery order with a completion date of December 10, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency awarded a $7,262.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by August 23, 2023 to fulfill DLA's requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,842 to Amerisourcebergen Drug Corporation for Nalbuphine hydrochloride injection. The single award was made against an existing Prime Vendor contract vehicle to supply 10mL vials of the narcotic analgesic medication. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with delivery required by June 22, 2023. No...
- The Defense Logistics Agency awarded a $6,334 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by July 11, 2023 to support Defense Logistics Agency requirements. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle but did not have any set aside designations....
- This federal contract award, valued at $1,353.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order contract is for the supply of 100 mg/10 mL vials of the drug Nalbuphine, a non-set-aside requirement. The contract has a ceiling value of $1,353.40 and is a Firm Fixed Price arrangement. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg/mL ampules of the drug nalbuphine, a non-narcotic analgesic medication, with a ceiling value of $1,963.91 and a completion date of March 10, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,824.74 firm fixed price contract is for the supply of 4564604895 - NALBUPHINE 200 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp, headquartered in Conshohocken, PA, is a major supplier of pharmaceutical products and...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQHT4Delivery Order
The Defense Logistics Agency awarded a $1,488.91 delivery order to AmerisourceBergen Drug Corp for Nalbuphine 100 mg/10 mL vials, a narcotic analgesic used for pain management. The contract, awarded June 2, 2025, with completion targeted for June 3, 2025, operates under a firm fixed price structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. The prime IDC enables AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/2/25 |